Sirtuins as biomarkers of accellerated cellular senescence in patients with Idiopathic Pulmonary Fibrosis (SIR-IPF)

<bold>Background:</bold> Idiopathic Pulmonary Fibrosis (IPF) is a progressive lung disease characterized by deposition of fibrotic tissue in the lungs. Sirtuins a family of proteins involved in different enzymatic reactions might have a role as biomarker of accellerated alveolar type-II senescence. <bold>Methods:</bold> We present a case-control study, involving IPF patients followed at ILD Clinic U.O.C. Vanvitelli, Monaldi Hospital, Naples, Italy. <bold>Results:</bold> 34 IPF patients and 19 age and gender-matched controls were recruited. Study population characteristics are reported in Table 1. Sirt-1 was lower in IPF versus controls (p <.001) while Sirt-3 was higher in IPF versus controls (p<.001). Sirt-1 was positively correlated with FEV1, FVC and DLco(Fig. 1); no significant association was present for Sirt-3. IPF patients with more severe GAP Stages expressed lower levels of Sirt-1 compared with GAP Stage I. <bold>Conclusions:</bold> This study provides novel data about the role of Sirtuins as biomarkers of accellerated senescene in IPF. <table-wrap><object-id>erj;64/suppl_68/PA3367/TB1</object-id><object-id>T1</object-id><object-id>TB1</object-id><table><colgroup><col></col><col></col><col></col><col></col></colgroup><tbody><tr><td></td><td><bold>IPF</bold></td><td><bold>Controls</bold></td><td><bold>p-value</bold></td></tr><tr><td><bold>Age</bold></td><td>75.0[69-77.1]</td><td>71.0 [67-77.0]</td><td>0.218</td></tr><tr><td><bold>Gender</bold></td><td>26(76.3)</td><td>12(63.2)</td><td>0.302</td></tr><tr><td><bold>Antibrotics</bold></td><td>30(88.2)</td><td>.</td><td>.</td></tr><tr><td><bold>GAP Index</bold></td><td>4 [3-5]</td><td>.</td><td>.</td></tr><tr><td><bold>FEV1%</bold></td><td>89.0 [77.0-102]</td><td>.</td><td>.</td></tr><tr><td><bold>FVC%</bold></td><td>81.0 [64.0-92.1]</td><td>.</td><td>.</td></tr><tr><td><bold>DLCO%</bold></td><td>46.9 [32.0-61.3]</td><td>.</td><td>.</td></tr><tr><td><bold>6MWD</bold></td><td>252 [208-396]</td><td>.</td><td>.</td></tr><tr><td><bold>Sirt-1</bold></td><td>667[435-858]</td><td>925[794-1173]</td><td><italic><.001</italic></td></tr><tr><td><bold>Sirt-3</bold></td><td>338[230-500]</td><td>154[99.8-246]</td><td><italic><.001</italic></td></tr><tr><td><bold>Sirt-6</bold></td><td>242[146-301]</td><td>263[238-328]</td><td>0.131</td></tr><tr><td><bold>Sirt-7</bold></td><td>4742[3622-6302]</td><td>4957[2112-5519]</td><td>0.522</td></tr></tbody></table></table-wrap> <fig><object-id>erj;64/suppl_68/PA3367/F1</object-id><object-id>F1</object-id><object-id>F1</object-id><graphic></graphic></fig>

Authors

Institutions

Publication Details

Published
2024-09-14
DOI
https://doi.org/10.1183/13993003.congress-2024.pa3367
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sirtuins as biomarkers of accellerated cellular senescence in patients with Idiopathic Pulmonary Fibrosis (SIR-IPF)

Filippo Scialò, Domenica Francesca Mariniello, Grazia Mazzeo, Vito D’Agnano et al.
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
article

Sirtuins as biomarkers of accellerated cellular senescence in patients with Idiopathic Pulmonary Fibrosis (SIR-IPF)

Filippo Scialò, Domenica Francesca Mariniello, Grazia Mazzeo, Vito D’Agnano, Fabio Perrotta, Ramona Fomez, Andrea Bianco, Linda Franzese
article en

Abstract

<bold>Background:</bold> Idiopathic Pulmonary Fibrosis (IPF) is a progressive lung disease characterized by deposition of fibrotic tissue in the lungs. Sirtuins a family of proteins involved in different enzymatic reactions might have a role as biomarker of accellerated alveolar type-II senescence. <bold>Methods:</bold> We present a case-control study, involving IPF patients followed at ILD Clinic U.O.C. Vanvitelli, Monaldi Hospital, Naples, Italy. <bold>Results:</bold> 34 IPF patients and 19 age and gender-matched controls were recruited. Study population characteristics are reported in Table 1. Sirt-1 was lower in IPF versus controls (p <.001) while Sirt-3 was higher in IPF versus controls (p<.001). Sirt-1 was positively correlated with FEV1, FVC and DLco(Fig. 1); no significant association was present for Sirt-3. IPF patients with more severe GAP Stages expressed lower levels of Sirt-1 compared with GAP Stage I. <bold>Conclusions:</bold> This study provides novel data about the role of Sirtuins as biomarkers of accellerated senescene in IPF. <table-wrap><object-id>erj;64/suppl_68/PA3367/TB1</object-id><object-id>T1</object-id><object-id>TB1</object-id><table><colgroup><col></col><col></col><col></col><col></col></colgroup><tbody><tr><td></td><td><bold>IPF</bold></td><td><bold>Controls</bold></td><td><bold>p-value</bold></td></tr><tr><td><bold>Age</bold></td><td>75.0[69-77.1]</td><td>71.0 [67-77.0]</td><td>0.218</td></tr><tr><td><bold>Gender</bold></td><td>26(76.3)</td><td>12(63.2)</td><td>0.302</td></tr><tr><td><bold>Antibrotics</bold></td><td>30(88.2)</td><td>.</td><td>.</td></tr><tr><td><bold>GAP Index</bold></td><td>4 [3-5]</td><td>.</td><td>.</td></tr><tr><td><bold>FEV1%</bold></td><td>89.0 [77.0-102]</td><td>.</td><td>.</td></tr><tr><td><bold>FVC%</bold></td><td>81.0 [64.0-92.1]</td><td>.</td><td>.</td></tr><tr><td><bold>DLCO%</bold></td><td>46.9 [32.0-61.3]</td><td>.</td><td>.</td></tr><tr><td><bold>6MWD</bold></td><td>252 [208-396]</td><td>.</td><td>.</td></tr><tr><td><bold>Sirt-1</bold></td><td>667[435-858]</td><td>925[794-1173]</td><td><italic><.001</italic></td></tr><tr><td><bold>Sirt-3</bold></td><td>338[230-500]</td><td>154[99.8-246]</td><td><italic><.001</italic></td></tr><tr><td><bold>Sirt-6</bold></td><td>242[146-301]</td><td>263[238-328]</td><td>0.131</td></tr><tr><td><bold>Sirt-7</bold></td><td>4742[3622-6302]</td><td>4957[2112-5519]</td><td>0.522</td></tr></tbody></table></table-wrap> <fig><object-id>erj;64/suppl_68/PA3367/F1</object-id><object-id>F1</object-id><object-id>F1</object-id><graphic></graphic></fig>

Federico II University Hospital (IT), University of Campania "Luigi Vanvitelli" (IT)
Zero hunger
Openalex Percentile: Top 63%
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.